These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 23079178)
1. Melanoma treatment costs: a systematic review of the literature, 1990-2011. Guy GP; Ekwueme DU; Tangka FK; Richardson LC Am J Prev Med; 2012 Nov; 43(5):537-45. PubMed ID: 23079178 [TBL] [Abstract][Full Text] [Related]
2. An estimate of the annual direct cost of treating cutaneous melanoma. Tsao H; Rogers GS; Sober AJ J Am Acad Dermatol; 1998 May; 38(5 Pt 1):669-80. PubMed ID: 9591809 [TBL] [Abstract][Full Text] [Related]
3. Melanoma costs: a dynamic model comparing estimated overall costs of various clinical stages. Alexandrescu DT Dermatol Online J; 2009 Nov; 15(11):1. PubMed ID: 19951637 [TBL] [Abstract][Full Text] [Related]
4. Confirming the timing of phase-based costing in oncology studies: a case example in advanced melanoma. Atkins M; Coutinho AD; Nunna S; Gupte-Singh K; Eaddy M J Med Econ; 2018 Feb; 21(2):212-217. PubMed ID: 29022427 [TBL] [Abstract][Full Text] [Related]
5. Economic burden of melanoma in the elderly population: population-based analysis of the Surveillance, Epidemiology, and End Results (SEER)--Medicare data. Seidler AM; Pennie ML; Veledar E; Culler SD; Chen SC Arch Dermatol; 2010 Mar; 146(3):249-56. PubMed ID: 20231494 [TBL] [Abstract][Full Text] [Related]
6. Years of potential life lost and indirect costs of melanoma and non-melanoma skin cancer: a systematic review of the literature. Guy GP; Ekwueme DU Pharmacoeconomics; 2011 Oct; 29(10):863-74. PubMed ID: 21846158 [TBL] [Abstract][Full Text] [Related]
7. Estimation of Direct Melanoma-related Costs by Disease Stage and by Phase of Diagnosis and Treatment According to Clinical Guidelines. Buja A; Sartor G; Scioni M; Vecchiato A; Bolzan M; Rebba V; Sileni VC; Palozzo AC; Montesco M; Del Fiore P; Baldo V; Rossi CR Acta Derm Venereol; 2018 Feb; 98(2):218-224. PubMed ID: 29110018 [TBL] [Abstract][Full Text] [Related]
8. Economic impact of healthcare resource utilisation patterns among patients diagnosed with advanced melanoma in the United Kingdom, Italy, and France: results from a retrospective, longitudinal survey (MELODY study). Johnston K; Levy AR; Lorigan P; Maio M; Lebbe C; Middleton M; Testori A; Bédane C; Konto C; Dueymes A; Sbarigia U; van Baardewijk M Eur J Cancer; 2012 Sep; 48(14):2175-82. PubMed ID: 22480965 [TBL] [Abstract][Full Text] [Related]
9. Health system costs of skin cancer and cost-effectiveness of skin cancer prevention and screening: a systematic review. Gordon LG; Rowell D Eur J Cancer Prev; 2015 Mar; 24(2):141-9. PubMed ID: 25089375 [TBL] [Abstract][Full Text] [Related]
10. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database. Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193 [TBL] [Abstract][Full Text] [Related]
11. Estimated Healthcare Costs of Melanoma in Australia Over 3 Years Post-Diagnosis. Elliott TM; Whiteman DC; Olsen CM; Gordon LG Appl Health Econ Health Policy; 2017 Dec; 15(6):805-816. PubMed ID: 28756584 [TBL] [Abstract][Full Text] [Related]
12. Modelling the healthcare costs of skin cancer in South Africa. Gordon LG; Elliott TM; Wright CY; Deghaye N; Visser W BMC Health Serv Res; 2016 Apr; 16():113. PubMed ID: 27039098 [TBL] [Abstract][Full Text] [Related]
13. Health Outcomes and Direct Healthcare Costs in Patients with Melanoma: Associations with Level of Education. Buja A; Rivera M; Zorzi M; Sperotto M; Baracco S; Italiano I; Vecchiato A; Del Fiore P; Avossa F; Corti MC; Guzzinati S; Saia M; Baldo V; Rugge M; Rossi CR Acta Derm Venereol; 2020 Jan; 100(1):adv00003. PubMed ID: 31580466 [No Abstract] [Full Text] [Related]
14. Cost of Cutaneous Melanoma by Tumor Stage: A Descriptive Analysis. Serra-Arbeloa P; Rabines-Juárez ÁO; Álvarez-Ruiz MS; Guillén-Grima F Actas Dermosifiliogr; 2017 Apr; 108(3):229-236. PubMed ID: 27887672 [TBL] [Abstract][Full Text] [Related]
15. Stage-specific direct health care costs in patients with cutaneous malignant melanoma. Lyth J; Carstensen J; Synnerstad I; Lindholm C J Eur Acad Dermatol Venereol; 2016 May; 30(5):789-93. PubMed ID: 25807966 [TBL] [Abstract][Full Text] [Related]
16. Cost-of-illness of melanoma in Europe - a modelling approach. Krensel M; Schäfer I; Augustin M J Eur Acad Dermatol Venereol; 2019 Mar; 33 Suppl 2():34-45. PubMed ID: 30811699 [TBL] [Abstract][Full Text] [Related]
17. Cost-of-illness of melanoma in Europe - a systematic review of the published literature. Krensel M; Schäfer I; Augustin M J Eur Acad Dermatol Venereol; 2019 Mar; 33(3):504-510. PubMed ID: 30408246 [TBL] [Abstract][Full Text] [Related]
18. Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study). McArthur GA; Mohr P; Ascierto PA; Arance A; Banos Hernaez A; Kaskel P; Weichenthal M; Shinde R; Stevinson K Oncologist; 2017 Aug; 22(8):951-962. PubMed ID: 28526721 [TBL] [Abstract][Full Text] [Related]
19. The economic burden of melanoma in France: assessing healthcare use in a hospital setting. Chevalier J; Bonastre J; Avril MF Melanoma Res; 2008 Feb; 18(1):40-6. PubMed ID: 18227707 [TBL] [Abstract][Full Text] [Related]
20. Costs of illness for melanoma and nonmelanoma skin cancer in Denmark. Bentzen J; Kjellberg J; Thorgaard C; Engholm G; Phillip A; Storm HH Eur J Cancer Prev; 2013 Nov; 22(6):569-76. PubMed ID: 23542376 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]